0.1800
0.0000
(0.00%)
At close: January 9 at 7:00:00 PM EST
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Operating Cash Flow
-15,660.0000
-15,660.0000
-8,140.0000
-10,193.0000
-7,803.0000
Investing Cash Flow
178.0000
178.0000
81.0000
-1,264.0000
-741.0000
Financing Cash Flow
10,390.0000
10,390.0000
-746.0000
-928.0000
46,079.0000
End Cash Position
14,817.0000
14,817.0000
19,920.0000
28,725.0000
41,110.0000
Capital Expenditure
-177.0000
-177.0000
-203.0000
-1,268.0000
-744.0000
Issuance of Capital Stock
11,989.0000
11,989.0000
166.0000
--
24,136.0000
Issuance of Debt
--
--
--
--
23,901.0000
Free Cash Flow
-15,837.0000
-15,837.0000
-8,343.0000
-11,461.0000
-8,547.0000
4/30/2021 - 8/2/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SBMJF Dimerix Limited
0.2650
0.00%
6XP.SG Xspray Pharma AB (publ)
2.9600
-6.03%
4YL.F Nanoform Finland Oyj
1.2720
-2.90%
0M4.F Mersana Therapeutics, Inc.
0.8396
-29.53%
XSPRAY.ST Xspray Pharma AB (publ)
29.25
-15.34%
5CV.DE CureVac N.V.
4.2660
+9.61%
CARA Cara Therapeutics, Inc.
4.7500
0.00%
MRSN Mersana Therapeutics, Inc.
0.7200
-44.62%
JAGX Jaguar Health, Inc.
1.0000
-8.26%